Vimarsana
Biggest News Aggregation in the World

For Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from For Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In For Global Today - Breaking & Trending Today

Junshi Biosciences Announces NDA Acceptance in Hong Kong - Vimarsana News

Junshi Biosciences Announces NDA Acceptance in Hong Kong

SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Junshi Biosciences Announces 2023 Full Year Financial - Vimarsana News

Junshi Biosciences Announces 2023 Full Year Financial

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates - Vimarsana News

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

Wexford authors Eoin Colfer and Serena Molloy shortlisted for prestigious children's books award - Vimarsana News

Wexford authors Eoin Colfer and Serena Molloy shortlisted for prestigious children's books award

Wexford authors Serena Molly and Eoin Colfer have been shortlisted for the 2024 KPMG Children’s Books Ireland Awards. In Eoin’s case, he has received nominations for two of his works, Global and Three Tasks for a Dragon. Originally from Wexford, Published by Walker Books and illustrated by P.J. Lynch, Three Tasks for a Dragon follows unlikely hero Prince Lir and not-so-helpless maiden Cethlenn.

Junshi Biosciences Announces Toripalimab's NDA Accepted by the Singapore Health Sciences Authority -February 01, 2024 at 10:41 pm EST - Vimarsana News

Junshi Biosciences Announces Toripalimab's NDA Accepted by the Singapore Health Sciences Authority -February 01, 2024 at 10:41 pm EST

SHANGHAI, China, Feb. 01, 2024 -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of...